Lipopolysaccharide and microbial biofilm components (LPS/MBC)

Lipopolysaccharide (LPS), also known as endotoxin, is a fundamental structural component of the outer membrane of Gram-negative bacteria, composed of Lipid A, a core oligosaccharide, and an O-antigen polysaccharide (Park & Lee, 2013, Exp Mol Med). It acts as a potent Pathogen-Associated Molecular Pattern (PAMP) that is recognized by the host Toll-like receptor 4 (TLR4) complex, initiating a robust innate immune response that can lead to systemic inflammatory response syndrome (SIRS) or septic shock (Alexander & Rietschel, 2001, J Endotoxin Res). Microbial biofilm components include a complex mixture of extracellular polymeric substances (EPS) such as polysaccharides, proteins, and extracellular DNA (eDNA) that encase bacterial communities, providing protection against host immune defenses and increasing antibiotic tolerance (Flemming & Wingender, 2010, Nat Rev Microbiol). Therapeutic interventions target these components through various means: cationic peptides like polymyxins bind and neutralize the toxic Lipid A portion of LPS, while enzymes like dornase alfa degrade eDNA to reduce the viscosity of biofilm-rich secretions in diseases like cystic fibrosis (Velkov et al., 2013, J Med Chem; Whitcher et al., 2001, Cochrane Database). Targeting these microbial structures is essential for managing acute bacterial toxemia and overcoming the physical barriers presented by chronic, biofilm-mediated infections.

Other names

EndotoxinLipoglycanExtracellular polymeric substances (EPS)Pathogen-associated molecular patterns (PAMPs)Biofilm matrixLipid AO-antigen

Drugs targeting these components typically work by binding and neutralizing the Lipid A moiety of lipopolysaccharide to prevent TLR4 activation, or by enzymatically degrading the extracellular polymeric substances (such as eDNA or polysaccharides) to disrupt the structural integrity of microbial biofilms and enhance antibiotic penetration.